Guwahati, Nov. 3 -- The Assam Drugs Control Administration has directed all retailers, distributors, stockists and hospitals across the state to sell 137 non-scheduled anti-cancer medicines at revised, reduced maximum retail prices (MRP) from November 9.

In a notice issued on Monday, the administration warned that a 90-day statewide inspection drive would be conducted to ensure compliance with the revised pricing norms.

The directive follows a Gazette notification issued by the National Pharmaceutical Pricing Authority (NPPA) on October 17, capping trade margins on the identified medicines at 30 per cent of their MRP. The NPPA invoked Paragraph 19 of the Drugs (Prices Control) Order, 2013, which empowers the regulator to intervene in th...